Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS??? EQUITY

v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Jan. 02, 2022   152,272,287      
Beginning balance at Jan. 02, 2022 $ 326,117 $ 15 $ 659,254   $ (333,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   91,910      
Issuance of common stock upon exercise of stock options 200   200    
Issuance of common stock upon exercise of common stock warrants (in shares)   4,126,466      
Issuance of common stock upon exercise of common stock warrants 47,452   47,452    
Early exercised stock options vested 42   42    
RSUs vested (in shares)   34,941      
Repurchase of unvested restricted common stock (in shares)   (105,886)      
Stock-based compensation 4,536   4,536    
Net (loss) income 42,707       42,707
Ending balance (in shares) at Apr. 03, 2022   156,419,718      
Ending balance at Apr. 03, 2022 421,054 $ 15 711,484   (290,445)
Beginning balance (in shares) at Jan. 02, 2022   152,272,287      
Beginning balance at Jan. 02, 2022 326,117 $ 15 659,254   (333,152)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Change in net unrealized loss on available-for-sale securities, net of tax 0        
Net (loss) income (40,441)        
Ending balance (in shares) at Oct. 02, 2022   157,077,599      
Ending balance at Oct. 02, 2022 358,283 $ 15 731,861   (373,593)
Beginning balance (in shares) at Apr. 03, 2022   156,419,718      
Beginning balance at Apr. 03, 2022 421,054 $ 15 711,484   (290,445)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   46,807      
Issuance of common stock upon exercise of stock options 77   77    
Issuance of common stock under employee stock purchase plan (in shares)   126,574      
Issuance of common stock under employee stock purchase plan 1,113   1,113    
Early exercised stock options vested 28   28    
RSUs vested (in shares)   115,990      
Repurchase of unvested restricted common stock (in shares)   (30,399)      
Stock-based compensation 7,603   7,603    
Net (loss) income (1,135)       (1,135)
Ending balance (in shares) at Jul. 03, 2022   156,678,690      
Ending balance at Jul. 03, 2022 428,740 $ 15 720,305   (291,580)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   204,483      
Issuance of common stock upon exercise of stock options 1,775   1,775    
Early exercised stock options vested 28   28    
RSUs vested (in shares)   209,156      
Repurchase of unvested restricted common stock (in shares)   (14,730)      
Stock-based compensation 9,753   9,753    
Change in net unrealized loss on available-for-sale securities, net of tax 0        
Net (loss) income (82,013)       (82,013)
Ending balance (in shares) at Oct. 02, 2022   157,077,599      
Ending balance at Oct. 02, 2022 $ 358,283 $ 15 731,861   (373,593)
Beginning balance (in shares) at Jan. 01, 2023 157,461,802 157,461,802      
Beginning balance at Jan. 01, 2023 $ 356,427 $ 15 741,186 $ 0 (384,774)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   86,654      
Issuance of common stock upon exercise of stock options 328   328    
Early exercised stock options vested 83 $ 1 82    
RSUs vested, net of shares withheld for taxes (in shares)   679,606      
RSUs vested, net of shares withheld for taxes (777)   (777)    
Repurchase of unvested restricted common stock (in shares)   (138,599)      
Stock-based compensation 29,653   29,653    
Net (loss) income (73,603)       (73,603)
Ending balance (in shares) at Apr. 02, 2023   158,089,463      
Ending balance at Apr. 02, 2023 $ 312,111 $ 16 770,472 0 (458,377)
Beginning balance (in shares) at Jan. 01, 2023 157,461,802 157,461,802      
Beginning balance at Jan. 01, 2023 $ 356,427 $ 15 741,186 0 (384,774)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,135,249        
Change in net unrealized loss on available-for-sale securities, net of tax $ (13)        
Net (loss) income $ (154,094)        
Ending balance (in shares) at Oct. 01, 2023 161,665,677 161,665,677      
Ending balance at Oct. 01, 2023 $ 252,475 $ 16 791,340 (13) (538,868)
Beginning balance (in shares) at Apr. 02, 2023   158,089,463      
Beginning balance at Apr. 02, 2023 312,111 $ 16 770,472 0 (458,377)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   93,921      
Issuance of common stock upon exercise of stock options 643   643    
Issuance of common stock under employee stock purchase plan (in shares)   146,278      
Issuance of common stock under employee stock purchase plan 1,170   1,170    
Early exercised stock options vested 14   14    
RSUs vested, net of shares withheld for taxes (in shares)   650,202      
RSUs vested, net of shares withheld for taxes (448)   (448)    
Repurchase of unvested restricted common stock (in shares)   (68,445)      
Stock-based compensation 15,374   15,374    
Purchase of Capped Calls (17,250)   (17,250)    
Change in net unrealized loss on available-for-sale securities, net of tax (24)     (24)  
Net (loss) income (64,306)       (64,306)
Ending balance (in shares) at Jul. 02, 2023   158,911,419      
Ending balance at Jul. 02, 2023 247,284 $ 16 769,975 (24) (522,683)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   954,674      
Issuance of common stock upon exercise of stock options 8,260   8,260    
Issuance of common stock subject to return (in shares)   1,304,954      
Early exercised stock options vested 22   22    
RSUs vested, net of shares withheld for taxes (in shares)   656,367      
RSUs vested, net of shares withheld for taxes (1,762)   (1,762)    
Repurchase of unvested restricted common stock (in shares)   (161,737)      
Stock-based compensation 14,845   14,845    
Change in net unrealized loss on available-for-sale securities, net of tax 11     11  
Net (loss) income $ (16,185)       (16,185)
Ending balance (in shares) at Oct. 01, 2023 161,665,677 161,665,677      
Ending balance at Oct. 01, 2023 $ 252,475 $ 16 $ 791,340 $ (13) $ (538,868)